Garner Asset Management Corp’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-1,688
| Closed | -$42K | – | 323 |
|
|
2025
Q4 | $42K | Buy |
+1,688
| New | +$42.6K | 0.02% | 242 |
|
|
2024
Q1 | – | Sell |
-6,807
| Closed | -$187K | – | 279 |
|
|
2023
Q4 | $187K | Sell |
6,807
-5,697
| -46% | -$172K | 0.09% | 139 |
|
|
2023
Q3 | $415K | Sell |
12,504
-270
| -2% | -$9.55K | 0.24% | 108 |
|
|
2023
Q2 | $469K | Sell |
12,774
-2,752
| -18% | -$107K | 0.26% | 106 |
|
|
2023
Q1 | $633K | Buy |
15,526
+5
| +0% | +$216 | 0.29% | 101 |
|
|
2022
Q4 | $795K | Sell |
15,521
-87
| -0.6% | -$4.17K | 0.38% | 87 |
|
|
2022
Q3 | $683K | Sell |
15,608
-1,627
| -9% | -$79.1K | 0.35% | 88 |
|
|
2022
Q2 | $904K | Buy |
17,235
+717
| +4% | +$36.5K | 0.39% | 83 |
|
|
2022
Q1 | $855K | Hold |
16,518
| – | – | 0.34% | 90 |
|
|
2021
Q4 | $975K | Sell |
16,518
-500
| -3% | -$24.8K | 0.4% | 81 |
|
|
2021
Q3 | $732K | Buy |
17,018
+14
| +0.1% | +$620 | 0.33% | 93 |
|
|
2021
Q2 | $666K | Sell |
17,004
-65
| -0.4% | -$2.53K | 0.31% | 100 |
|
|
2021
Q1 | $618K | Buy |
17,069
+2,730
| +19% | +$96.9K | 0.31% | 100 |
|
|
2020
Q4 | $528K | Buy |
14,339
+4,271
| +42% | +$157K | 0.29% | 105 |
|
|
2020
Q3 | $351K | Buy |
10,068
+108
| +1% | +$3.79K | 0.23% | 120 |
|
|
2020
Q2 | $309K | Buy |
9,960
+1,465
| +17% | +$49.8K | 0.23% | 119 |
|
|
2020
Q1 | $263K | Sell |
8,495
-184
| -2% | -$6.27K | 0.24% | 112 |
|
|
2019
Q4 | $323K | Hold |
8,679
| – | – | 0.22% | 112 |
|
|
2019
Q3 | $296K | Sell |
8,679
-894
| -9% | -$32.5K | 0.22% | 112 |
|
|
2019
Q2 | $393K | Buy |
9,573
+317
| +3% | +$12.6K | 0.3% | 101 |
|
|
2019
Q1 | $373K | Buy |
9,256
+61
| +0.7% | +$2.44K | 0.3% | 99 |
|
|
2018
Q4 | $381K | Hold |
9,195
| – | – | 0.34% | 92 |
|
|
2018
Q3 | $384K | Hold |
9,195
| – | – | 0.29% | 101 |
|
|
2018
Q2 | $317K | Buy |
9,195
+58
| +0.6% | +$1.98K | 0.25% | 110 |
|
|
2018
Q1 | $308K | Buy |
9,137
+450
| +5% | +$15.5K | 0.26% | 111 |
|
|
2017
Q4 | $299K | Buy |
8,687
+88
| +1% | +$3K | 0.25% | 118 |
|
|
2017
Q3 | $291K | Sell |
8,599
-158
| -2% | -$5.08K | 0.26% | 116 |
|
|
2017
Q2 | $279K | Buy |
+8,757
| New | +$276K | 0.26% | 117 |
|
Other funds holding PFE
Garner Asset Management Corp's PFE Position: Q1 2026 in Review
Garner Asset Management Corp sold out of Pfizer (PFE) in Q1 2026, closing a stake of 1,688 shares — an estimated $42K sold.
Garner Asset Management Corp first reported a position in PFE in Q2 2017 and held it in 28 quarters. The position peaked at $975K in Q4 2021. 2,959 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Garner Asset Management Corp reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
- Garner Asset Management Corp sold 1,688 Pfizer shares in Q1 2026, an estimated $42K.
- Garner Asset Management Corp first reported a position in Pfizer in Q2 2017 and held it in 28 quarters.
- Garner Asset Management Corp's Pfizer position peaked at $975K in Q4 2021.
- 2,959 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Garner Asset Management Corp's 13F filing for Q1 2026, filed 29 Apr 2026.